Intelligent Bio Solutions Inc (INBS)
Intelligent Bio Solutions Inc. is a healthcare technology company listed on NASDAQ under the ticker INBS. The company develops non-invasive testing and screening solutions for use in Asia Pacific, the United States, the United Kingdom, and other international markets. Its product platform includes an intelligent fingerprinting drug screening system that uses fingerprint sweat analysis to detect drug use, along with a biosensor platform. Founded in 2016 and headquartered in New York, New York, the company was previously known as GBS Inc. before adopting its current name in October 2022.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-INBS
|
$3.03
|
58.5% Upside
|
Bargain
|
$12
|
528.3% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 14, 2026
|
-0.4x
|
0.5x
|
1.1x
|
4.712 M
|
-727.359 K
|
29.1%
|
90.8%
|
-18.3
|
—
|
97.2%
|
